1AD 3.85% 2.5¢ adalta limited

Ann: Investor webinar presentation, page-6

  1. 780 Posts.
    lightbulb Created with Sketch. 197
    Yes Beno very likely in the next few weeks a pharma company will offer you 3 x market cap for a share of revenue in a pre phase 2 asset that has absolutely no human efficacy data whatsoever. Sounds very very plausible.
 
watchlist Created with Sketch. Add 1AD (ASX) to my watchlist
(20min delay)
Last
2.5¢
Change
-0.001(3.85%)
Mkt cap ! $14.89M
Open High Low Value Volume
2.5¢ 2.5¢ 2.5¢ $229 9.16K

Buyers (Bids)

No. Vol. Price($)
3 2279372 2.5¢
 

Sellers (Offers)

Price($) Vol. No.
2.6¢ 687066 3
View Market Depth
Last trade - 11.43am 18/06/2024 (20 minute delay) ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.